Push Health vs Hims for Peptide Prescriptions

Push Health and Hims represent two distinct approaches to peptide prescriptions for weight management. Push Health operates as a telemedicine marketplace connecting patients with independent physicians, while Hims functions as a direct-to-consumer platform with in-house medical teams.

Both platforms offer access to GLP-1 receptor agonists like semaglutide, but they differ significantly in pricing structure, medication options, and the level of ongoing medical support. This comparison examines pricing, available treatments, physician oversight, and patient experience to help you determine which platform better suits your weight management goals.

Our clinical team analyzed current offerings from both platforms, reviewed patient feedback, and compared costs to provide you with an evidence-based assessment. Whether you prioritize physician choice flexibility or prefer a streamlined all-in-one experience will largely determine which option serves you better.

Push Health: What You Get

Push Health positions itself as a telemedicine marketplace rather than a traditional telehealth clinic. The platform connects patients with licensed physicians across multiple states, allowing you to choose from available providers based on their specialties, reviews, and consultation fees.

The consultation process begins with selecting a physician from their directory. Consultation fees typically range from $65 to $150, depending on the provider and complexity of your case. After completing a medical questionnaire, you schedule a video or phone consultation with your chosen physician. The doctor reviews your medical history, discusses treatment options, and can prescribe appropriate medications if clinically indicated.

For peptide prescriptions, Push Health physicians commonly prescribe semaglutide and tirzepatide. The platform doesn't operate its own pharmacy, so prescriptions are sent to your preferred pharmacy or a partner compounding facility. This flexibility allows you to use insurance coverage if available for the medication itself, though consultation fees are typically out-of-pocket.

Medication costs vary significantly based on whether you choose brand-name products like Ozempic or Wegovy, or opt for compounded versions. Brand-name semaglutide can cost $800-$1,400 monthly without insurance, while compounded versions typically range from $200-$400 monthly through partner pharmacies.

The platform's strength lies in physician choice and flexibility. You can read provider profiles, view their credentials, and select someone who specializes in weight management or metabolic health. Some physicians on the platform offer follow-up consultations at reduced rates, though this varies by provider.

Push Health Pros:

• Choose from multiple licensed physicians
• Flexible pharmacy options
• Potential insurance coverage for medications
• Transparent provider profiles and pricing
• Access to both brand-name and compounded medications

Push Health Cons:

• Higher upfront consultation costs
• No standardized follow-up protocol
• Medication costs not included in consultation fee
• Limited ongoing support unless arranged separately
• Prescription fulfillment depends on external pharmacies

Hims: What You Get

Hims operates as an integrated telehealth platform specializing in men's health, though they've expanded to offer weight management solutions for all patients. Their approach emphasizes convenience and standardization, with a streamlined process from consultation to medication delivery.

The Hims weight management program starts at $49 monthly for the basic plan, which includes an initial consultation, ongoing messaging support with healthcare providers, and access to educational resources. However, this doesn't include medication costs. Their GLP-1 program specifically costs $199-$399 monthly, depending on the medication strength and whether you choose brand-name or compounded semaglutide.

The consultation process is entirely online through their platform. You complete a comprehensive medical questionnaire covering your weight history, current medications, and health conditions. A licensed healthcare provider reviews your information and determines if you're a candidate for GLP-1 therapy. If approved, they prescribe the appropriate medication and dosage.

Currently, Hims primarily offers semaglutide for weight management, available in both brand-name (Wegovy) and compounded formulations. The compounded version costs significantly less than brand-name options, making it more accessible for patients without insurance coverage. All medications are shipped directly to your address in discreet packaging.

One of Hims' key advantages is their integrated approach to ongoing care. The platform includes messaging access to healthcare providers for questions about side effects, dosage adjustments, or general concerns. They also provide educational content about nutrition, exercise, and lifestyle modifications to support your weight loss process.

The platform's technology focuses on user experience, with a mobile app for tracking progress, scheduling follow-ups, and communicating with providers. Automatic refills ensure you don't miss doses, and they send reminders for injection schedules and follow-up consultations.

Hims Pros:

• All-inclusive monthly pricing
• Ongoing provider messaging support
• Streamlined prescription fulfillment
• Mobile app for progress tracking
• Educational resources and lifestyle support
• Automatic refill management

Hims Cons:

• Limited medication options (primarily semaglutide)
• No physician choice flexibility
• Higher total monthly costs
• No insurance acceptance for consultations
• Standardized approach may not suit all patients

Price Comparison: Push Health vs Hims

The cost structures between Push Health and Hims differ fundamentally, making direct comparison challenging. Push Health operates on a consultation-plus-medication model, while Hims bundles services into monthly subscriptions.

For Push Health, you'll pay $65-$150 for the initial consultation, then separate costs for medications. If choosing compounded semaglutide through partner pharmacies, expect $200-$400 monthly for the medication itself. This brings your total first-month cost to approximately $265-$550, with subsequent months costing $200-$400 for medication alone.

Hims charges $199-$399 monthly for their complete GLP-1 program, including consultation, ongoing support, and compounded semaglutide. Their pricing is transparent and predictable, though higher than Push Health's medication-only costs in subsequent months.

Over a six-month treatment period, Push Health typically costs $1,365-$2,550 (including one consultation), while Hims costs $1,194-$2,394. However, Push Health offers more flexibility in medication choice and pharmacy selection, potentially leading to cost savings if you find better pricing elsewhere.

Neither platform accepts insurance for consultations, but Push Health's pharmacy flexibility means you might use insurance coverage for brand-name medications if your plan covers them. This could significantly reduce costs for patients with comprehensive prescription coverage.

Medication Options: Push Health vs Hims

The range of available peptide medications represents a significant differentiator between these platforms. Push Health's marketplace model provides access to a broader spectrum of treatments, while Hims focuses on proven, FDA-approved options with standardized protocols.

Push Health physicians can prescribe various GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda). The platform's flexibility extends to both brand-name and compounded formulations, giving patients and physicians more options to find the most suitable and affordable treatment.

Some Push Health providers also prescribe combination therapies or off-label uses of these medications, provided they determine it's clinically appropriate. This flexibility can be valuable for patients who don't respond well to standard protocols or have specific medical considerations requiring customized approaches.

Hims currently focuses primarily on semaglutide, offering both brand-name Wegovy and compounded versions. Their standardized approach ensures consistent quality and dosing protocols, but limits options for patients who might benefit from alternative medications like tirzepatide or combination therapies.

The compounded semaglutide offered through Hims comes from FDA-registered 503B facilities, ensuring pharmaceutical-grade quality. Their dosing protocols follow established clinical guidelines, starting at lower doses and gradually increasing based on tolerance and effectiveness.

For patients specifically seeking tirzepatide, which has shown superior weight loss results in clinical trials compared to semaglutide, Push Health provides better access through its network of physicians. Hims has not yet added tirzepatide to their standard offerings, though this may change as the medication becomes more widely available.

Doctor Quality and Oversight

The quality and accessibility of medical oversight differs substantially between these platforms, reflecting their distinct operational models. Push Health's marketplace approach provides transparency in physician credentials but less standardization in care protocols.

Push Health displays detailed physician profiles including medical school, residency training, board certifications, and patient reviews. You can specifically choose providers who specialize in obesity medicine, endocrinology, or metabolic health. This transparency allows you to select physicians whose expertise aligns with your specific needs and preferences.

However, the quality of ongoing care varies by individual physician. Some providers offer comprehensive follow-up protocols with regular check-ins, while others provide minimal ongoing support after the initial prescription. You'll need to clarify follow-up expectations and costs during your initial consultation.

Hims employs licensed healthcare providers who follow standardized protocols for weight management consultations and follow-up care. While you don't choose your specific provider, all clinicians receive training in their weight management protocols and use evidence-based guidelines for prescribing and monitoring.

The Hims platform includes built-in safety monitoring with regular check-ins about side effects, weight loss progress, and any concerning symptoms. Their providers are available through secure messaging for questions between scheduled consultations, providing more accessible ongoing support than many Push Health physicians offer.

Both platforms require providers to be licensed in your state of residence and follow appropriate prescribing guidelines. However, Hims' standardized approach may provide more consistent care quality, while Push Health offers the potential for more specialized expertise if you choose the right physician.

Patient Experience and Reviews

Patient feedback reveals distinct satisfaction patterns between these platforms, largely reflecting their different approaches to service delivery and customer support. Push Health users frequently praise the physician selection flexibility but note inconsistencies in follow-up care quality.

Common positive feedback for Push Health includes appreciation for transparent pricing, ability to choose specialized physicians, and flexibility in pharmacy selection. Patients with complex medical histories particularly value being able to select physicians with relevant expertise in endocrinology or obesity medicine.

However, Push Health users sometimes report frustration with variable follow-up protocols and additional costs for ongoing consultations. Some patients find the marketplace model confusing initially, particularly when comparing different physicians' approaches and fees.

Hims receives positive reviews for their streamlined user experience and consistent customer support. Patients appreciate the predictable monthly pricing, easy medication refills, and accessible provider messaging. The mobile app functionality receives particularly strong feedback for progress tracking and appointment scheduling.

Negative Hims reviews often center on limited medication options and the standardized approach that may not suit all patients. Some users want access to newer medications like tirzepatide or prefer more personalized treatment protocols than Hims currently offers.

Shipping and fulfillment experiences generally favor Hims due to their integrated supply chain, with most patients receiving medications within 2-3 business days. Push Health's pharmacy flexibility can sometimes lead to longer fulfillment times, particularly for compounded medications.

Both platforms maintain high overall satisfaction ratings, but patient preferences often align with their priorities: those wanting physician choice and flexibility tend to prefer Push Health, while patients prioritizing convenience and standardized care gravitate toward Hims.

Which Is Right for You?

Choosing between Push Health and Hims depends on your priorities, medical complexity, and preferences for healthcare delivery. Each platform serves different patient profiles effectively, and understanding these distinctions will guide your decision.

Choose Push Health if you:

• Want to select your own physician based on credentials and specialization
• Prefer flexibility in medication options, including access to tirzepatide
• Have insurance coverage that might apply to prescription medications
• Don't mind managing separate relationships with physicians and pharmacies
• Have complex medical conditions requiring specialized expertise
• Prefer lower ongoing costs after the initial consultation

Choose Hims if you:

• Want predictable, all-inclusive monthly pricing
• Prefer streamlined, standardized care protocols
• Value ongoing provider messaging support
• Want integrated progress tracking and medication management
• Don't need access to medications beyond semaglutide
• Prioritize convenience and user experience over physician choice

For patients seeking a middle ground between flexibility and convenience, FormBlends offers physician-supervised telehealth with both standardized protocols and personalized treatment options. Our clinical team provides access to multiple GLP-1 medications including both semaglutide and tirzepatide, with transparent pricing and ongoing medical oversight.

Frequently Asked Questions

Do Push Health or Hims accept insurance for peptide prescriptions?

Neither platform accepts insurance for consultation fees, but Push Health's pharmacy flexibility allows potential insurance coverage for medications themselves. Hims operates entirely cash-pay for both consultations and medications. If you have prescription coverage, Push Health may offer better overall value through insurance benefits.

Which platform offers better access to tirzepatide (Mounjaro/Zepbound)?

Push Health provides better access to tirzepatide through its network of physicians who can prescribe various GLP-1 medications based on clinical judgment. Hims currently focuses primarily on semaglutide and doesn't routinely offer tirzepatide prescriptions. Patients specifically seeking tirzepatide should consider Push Health or alternative providers.

How do follow-up appointments work with each platform?

Push Health follow-up protocols vary by individual physician, with some offering reduced-rate follow-ups and others charging full consultation fees. Hims includes ongoing provider messaging and scheduled check-ins as part of their monthly subscription, providing more standardized ongoing support without additional consultation fees.

Can I switch between brand-name and compounded medications on these platforms?

Push Health offers more flexibility for switching between different medication formulations based on your physician's recommendations and pharmacy options. Hims typically maintains consistent medication sourcing through their supply chain, though they may accommodate switches based on availability and clinical needs.

What happens if I experience side effects with either platform?

Both platforms provide access to medical support for side effects, but the response mechanisms differ. Hims offers immediate messaging support with standardized protocols for common side effects. Push Health support depends on your chosen physician's availability and follow-up policies, which may vary significantly between providers.

Ready to Start Your Weight Loss Goals?

Both Push Health and Hims offer legitimate pathways to accessing peptide medications for weight management, each with distinct advantages depending on your needs and preferences. The choice ultimately comes down to whether you prioritize physician selection flexibility or prefer an integrated, standardized approach.

For patients seeking comprehensive care that combines the best of both approaches, FormBlends provides physician-supervised telehealth with personalized treatment protocols and access to multiple GLP-1 medications. Our clinical team offers transparent pricing, ongoing medical oversight, and flexible treatment options tailored to your specific needs.

Before starting any weight management program, consult with a qualified healthcare provider to determine the most appropriate treatment approach for your individual health profile and goals. Explore our comparison guides for additional insights into telehealth platforms and weight management options.

Sources

1. Push Health. Telemedicine Platform and Pricing. Available at: https://pushhealth.com. Accessed March 2026.

2. Hims & Hers Health. Weight Management Program Details. Available at: https://forhims.com. Accessed March 2026.

3. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002.

4. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216.

5. FDA. Information about Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors. Available at: https://www.fda.gov. Accessed March 2026.

6. American Society of Bariatric Physicians. Clinical Guidelines for Weight Management. 2025.